Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …

Coronavirus disease 2019 (COVID-19) is a viral infection caused by SARS-CoV-2 that
induces a generalized inflammatory state. Organokines (adipokines, osteokines, myokines …

Obesity is recognized as a risk factor for adverse outcome in COVID‐19, but the molecular
mechanisms underlying this relationship remain unknown. Adipose tissue functions as an …

Adiponectin (APN) is an adipokine concerned in the regulation of glucose metabolism,
insulin sensitivity and fatty acid oxidation. APN plays a critical role in viral infections by …

Abstract Obesity, type 2 diabetes (T2DM), hypertension (HTN), and Cardiovascular Disease
(CVD) often cluster together as “Cardiometabolic Disease”(CMD). Just under 50% of …

About one-fourth of the global population is either overweight or obese, both of which
increase the risk of insulin resistance, cardiovascular diseases, and infections. In obesity …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to a global health
outbreak known as the COVID-19 pandemic which has been lasting since March 2020 …

Background. Chronic low‐grade inflammation associated with a dysregulated adipose
tissue might contribute to amplifying the inflammatory response in severe COVID‐19. The …

Although many efforts have been made to understand the pathophysiological mechanisms
of COVID-19, critical gaps remain to be explored. This study aimed to investigate potential …

Background Altered levels of some blood markers might be linked with the degree of
severity and mortality of patients with SARS-CoV-2 infection. This study aimed to find out if …